Canada - English - Health Canada

sandoz canada incorporated - felodipine - tablet (extended-release) - 5mg - felodipine 5mg - dihydropyridines

Canada - English - Health Canada

sandoz canada incorporated - felodipine - tablet (extended-release) - 10mg - felodipine 10mg - dihydropyridines

Ireland - English - HPRA (Health Products Regulatory Authority)

selana healthcare ltd - felodipine - tablet prolonged release - 10 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

selana healthcare ltd - felodipine - tablet prolonged release - 5 milligram

Canada - English - Health Canada

sanofi-aventis canada inc - felodipine; ramipril - tablet - 5mg; 5mg - felodipine 5mg; ramipril 5mg - dihydropyridines

Canada - English - Health Canada

sanofi-aventis canada inc - felodipine; ramipril - tablet - 2.5mg; 2.5mg - felodipine 2.5mg; ramipril 2.5mg - dihydropyridines

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - felodipine - tablets extended release - felodipine 2.5 mg - felodipine - felodipine - hypertension. angina pectoris.

United States - English - NLM (National Library of Medicine)

yung shin pharmaceutical ind. co., ltd. - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine extended-release tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic cla

United States - English - NLM (National Library of Medicine)

method pharmacueticals, llc - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine extended-release tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic class

United States - English - NLM (National Library of Medicine)

carlsbad technology, inc. - felodipine (unii: ol961r6o2c) (felodipine - unii:ol961r6o2c) - felodipine extended-release tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint nat